Role of Progranulin in Mediating the Anti-Inflammatory Property of High-Density L

颗粒体蛋白前体在介导高密度 L 抗炎特性中的作用

基本信息

  • 批准号:
    8397621
  • 负责人:
  • 金额:
    $ 5.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-16 至 2015-08-15
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): High-density lipoprotein (HDL) is the smallest, most dense lipoprotein in plasma. Epidemiological studies from the past four decades have consistently found that HDL levels are inversely correlated with the incidence of cardiovascular disease. The protective effect of HDL is largely attributed to either its role in reverse cholesterl transport or its anti-inflammatory property. The anti-inflammatory property was described in 1995, based on HDL's ability to block TNF-a-induced expression of the cellular adhesion molecules VCAM-1 and ICAM-1 in endothelial cells. Although numerous studies have confirmed this finding, the mechanism underlying this anti-inflammatory property remains unknown. I propose to focus on a new candidate for mediating HDL's anti-inflammatory property. Progranulin is a secreted growth factor that is expressed in many tissues and circulates in the blood. The progranulin gene, GRN, is mutated in some cases of familial frontotemporal dementia. Progranulin has been reported to be associated with HDL. Interestingly, recent studies revealed that progranulin binds to TNF receptors, thereby establishing a link between progranulin and inflammation. Specifically, current models posit that progranulin antagonizes TNF signaling by competing with TNF-a for binding to TNF receptors. Further, mice lacking progranulin have enhanced susceptibility to collagen-induced arthritis, illustrating functional consequences involving inflammation. This raises the intriguing hypothesis that progranulin significantly contributes to the anti-inflammatory property of HDL. Completion of these studies is expected to provide important insights into the molecular basis underlying HDL's anti-inflammatory property. Knowledge gleaned from these studies will likely have therapeutic implications for the prevention and treatment of cardiovascular disease. Moreover, it would be directly relevant to individuals with mutations in the GRN gene, which is mutated in some cases of frontotemporal dementia. PUBLIC HEALTH RELEVANCE: In this proposal, I will test the role of progranulin in mediating the anti-inflammatory property of HDL cholesterol, which is one mechanism by which HDL is thought to protect against cardiovascular disease. I will also determine the functional importance of progranulin using a mouse model of atherosclerosis. Completion of these studies is expected to provide important insights about the molecular basis underlying HDL's anti-inflammatory property, which would likely have therapeutic implications for the prevention and treatment of cardiovascular disease.
描述(由申请人提供):高密度脂蛋白(HDL)是血浆中最小、密度最大的脂蛋白。过去四十年的流行病学研究一致发现,HDL水平与心血管疾病的发病率呈负相关。HDL的保护作用主要归因于其在胆固醇逆向转运中的作用或其抗炎性质。1995年,基于HDL阻断TNF-α诱导的内皮细胞中细胞粘附分子VCAM-1和ICAM-1表达的能力,描述了抗炎特性。尽管许多研究已经证实了这一发现,但这种抗炎特性的机制仍然未知。我建议把重点放在一个新的候选人介导高密度脂蛋白的抗炎性质。颗粒蛋白原是一种分泌的生长因子,在许多组织中表达并在血液中循环。在家族性额颞叶痴呆的某些病例中,颗粒蛋白前体基因GRN发生突变。据报道,颗粒蛋白前体与HDL相关。有趣的是,最近的研究表明,颗粒蛋白前体与TNF受体结合,从而建立了颗粒蛋白前体与炎症之间的联系。具体地,目前的模型证实颗粒蛋白前体通过与TNF-α竞争结合TNF受体来拮抗TNF信号传导。此外,缺乏颗粒蛋白前体的小鼠对胶原诱导的关节炎的易感性增强,说明了涉及炎症的功能后果。这提出了一个有趣的假设,即颗粒蛋白前体显著有助于HDL的抗炎特性。这些研究的完成有望为HDL抗炎特性的分子基础提供重要的见解。从这些研究中收集的知识可能对预防和治疗心血管疾病具有治疗意义。此外,它与GRN基因突变的个体直接相关,GRN基因在某些额颞叶痴呆症病例中发生突变。 公共卫生关系:在这个提议中,我将测试颗粒蛋白前体在介导HDL胆固醇的抗炎特性中的作用,这是HDL被认为可以预防心血管疾病的一种机制。我还将使用动脉粥样硬化小鼠模型确定颗粒蛋白前体的功能重要性。这些研究的完成有望为HDL抗炎特性的分子基础提供重要的见解,这可能对预防和治疗心血管疾病具有治疗意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrew D. Nguyen其他文献

Coblation of spinal endplates in preparation for interbody spinal fusion
  • DOI:
    10.1016/j.jocn.2005.04.027
  • 发表时间:
    2006-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Henry E. Aryan;Christopher P. Ames;Bartek Szandera;Andrew D. Nguyen;Frank L. Acosta;William R. Taylor
  • 通讯作者:
    William R. Taylor
Adropin expression reflects circadian, lipoprotein, and mitochondrial processes in human tissues
Adropin 表达反映了人体组织中的昼夜节律、脂蛋白和线粒体过程
  • DOI:
    10.1016/j.molmet.2025.102196
  • 发表时间:
    2025-09-01
  • 期刊:
  • 影响因子:
    6.600
  • 作者:
    Joseph R. Stevens;Clemence Girardet;Mingqi Zhou;Farah Gamie;Geetika Aggarwal;Ryan P. McMillan;Matthew W. Hulver;Laurent O. Martinez;Marcel van der Brug;Bruno Vellas;Andrew D. Nguyen;Marcus M. Seldin;Andrew A. Butler;MAPT Study Group;Principal investigator;Bruno Vellas;Coordination;Sophie Guyonnet;Project leader;Isabelle Carrié
  • 通讯作者:
    Isabelle Carrié
Catch me if you can: Under-detection of Trypanosoma cruzi (Kinetoplastea: Trypanosomatida) infections in Triatoma dimidiata s.l. (Hemiptera: Reduviidae) from Central America.
如果可以的话请联系我:Triatoma dimidiata s.l. 中克氏锥虫(Kinetoplastea:Trypanosomatida)感染的检测不足。
  • DOI:
    10.1016/j.actatropica.2021.106130
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    L. Stevens;R. Lima;S. Cahan;P. Dorn;C. Monroy;Heather J. Axen;Andrew D. Nguyen;Yainna Hernáiz;A. Rodas;S. A. Justi
  • 通讯作者:
    S. A. Justi
Population genomics supports multiple hybrid zone origins of socially hybridogenetic lineages of Pogonomyrmex harvester ants
群体基因组学支持 Pogonomyrmex 收获蚁社会杂交谱系的多个杂交区起源

Andrew D. Nguyen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrew D. Nguyen', 18)}}的其他基金

Antisense Oligonucleotides for Targeting Nonsense-mediated mRNA Decay in Frontotemporal Dementia
反义寡核苷酸用于靶向额颞叶痴呆中无义介导的 mRNA 衰减
  • 批准号:
    10621865
  • 财政年份:
    2019
  • 资助金额:
    $ 5.39万
  • 项目类别:
Antisense Oligonucleotides for Targeting Nonsense-mediated mRNA Decay in Frontotemporal Dementia
反义寡核苷酸用于靶向额颞叶痴呆中无义介导的 mRNA 衰减
  • 批准号:
    10153636
  • 财政年份:
    2019
  • 资助金额:
    $ 5.39万
  • 项目类别:
Antisense Oligonucleotides for Targeting Nonsense-mediated mRNA Decay in Frontotemporal Dementia
反义寡核苷酸用于靶向额颞叶痴呆中无义介导的 mRNA 衰减
  • 批准号:
    10402795
  • 财政年份:
    2019
  • 资助金额:
    $ 5.39万
  • 项目类别:
Mapping Progranulin's Bioactivity: Implications for Disease and Potential Therapies
绘制颗粒体蛋白前体的生物活性:对疾病和潜在疗法的影响
  • 批准号:
    9913313
  • 财政年份:
    2018
  • 资助金额:
    $ 5.39万
  • 项目类别:
Mapping Progranulin's Bioactivity: Implications for Disease and Potential Therapies
绘制颗粒体蛋白前体的生物活性:对疾病和潜在疗法的影响
  • 批准号:
    9762766
  • 财政年份:
    2018
  • 资助金额:
    $ 5.39万
  • 项目类别:
Mapping Progranulin's Bioactivity: Implications for Disease and Potential Therapi
绘制颗粒体蛋白前体的生物活性:对疾病和潜在治疗的影响
  • 批准号:
    8918399
  • 财政年份:
    2014
  • 资助金额:
    $ 5.39万
  • 项目类别:
Role of Progranulin in Mediating the Anti-Inflammatory Property of High-Density L
颗粒体蛋白前体在介导高密度 L 抗炎特性中的作用
  • 批准号:
    8706956
  • 财政年份:
    2012
  • 资助金额:
    $ 5.39万
  • 项目类别:
Role of Progranulin in Mediating the Anti-Inflammatory Property of High-Density L
颗粒体蛋白前体在介导高密度 L 抗炎特性中的作用
  • 批准号:
    8531709
  • 财政年份:
    2012
  • 资助金额:
    $ 5.39万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 5.39万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 5.39万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 5.39万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 5.39万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 5.39万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 5.39万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 5.39万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 5.39万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 5.39万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 5.39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了